benefit risk [qlco]
adjuvant therapy [topp]
Breast Cancer [neop]
Tamoxifen [orch, phsu]
Aromatase inhibitor [phsu]
Age [orga]
Race [popg]
Ethnicity [popg]
Adjuvant Trial [resa]
Breast Cancer [neop]
Reports [inpr]
Aromatase Inhibitors [phsu]
Reduced [qlco]
Breast [bpoc]
Low Risk [fndg]
Thromboembolic events [patf]
Endometrial Cancer [neop]
Tamoxifen [orch, phsu]
Aromatase Inhibitors [phsu]
Fracture [inpo]
Cardiovascular disease [dsyn]
Update [tmco]
meta-analyses [resa]
Adjuvant Trials [resa]
Benefits [qnco]
Agent [chvf]
Various [irda]
baseline [bodm]
Incidence Rate [qnco]
Health Outcomes [inpr]
Age [orga]
Race [popg]
Ethnicity [popg]
Absent [qnco]
Aromatase inhibitor [phsu]
Tamoxifen [orch, phsu]
Estimated [qnco]
Initiative [menp]
Aromatase inhibitor [phsu]
Tamoxifen [orch, phsu]
effects [qlco]
Distant [spco]
Obtained [ftcn]
Meta-Analysis [inpr]
Arimidex [orch, phsu]
Tamoxifen [orch, phsu]
Alone [qnco]
Combination [qlco]
Breast [bpoc]
International [idcn]
Group [idcn]
BIG-1 [gngm]
Clinical Trials [resa]
IMPACT [gngm]
Health Outcomes [inpr]
Obtained [ftcn]
meta-analyses [resa]
randomized [resa]
Trial [resa]
Aromatase inhibitor [phsu]
Tamoxifen [orch, phsu]
placebo-controlled [resa]
Chemoprevention [topp]
Trial [resa]
Health Outcomes [inpr]
GIVEN [cnce]
Equal [qlco]
weight [orga]
Modeling [inpr, resa]
Reticular [spco]
benefit risk [qlco]
Aromatase inhibitor [phsu]
Compared [acty]
Tamoxifen [orch, phsu]
Breast Cancer [neop]
Recurrence Risk [qnco]
Age [orga]
Decade [qnco]
Race [popg]
Ethnicity [popg]
Hysterectomy [topp]
yes/no [clas]
Prior [tmco]
Myocardial Infarction [dsyn]
A-10 [orch, phsu]
benefit risk [qlco]
Index [inpr]
Favorable [qlco]
Aromatase inhibitor [phsu]
Tamoxifen [orch, phsu]
adjuvant therapy [topp]
Breast Cancer [neop]
Age [orga]
Race [popg]
Ethnicity [popg]
Breast Cancer [neop]
Recurrence Risk [qnco]
absence [qnco]
Uterus [bpoc]
Old [tmco]
Women [popg]
Prior [tmco]
Myocardial Infarction [dsyn]
Low Risk [fndg]
Tamoxifen [orch, phsu]
Seen [qlco]
benefit risk [qlco]
Index [inpr]
Endocrine therapy [topp]
Adjuvant [chvf]
Breast Cancer [neop]
postmenopausal [tmco]
Women [popg]
Benefit [qnco]
Aromatase inhibitor [phsu]
